ESC 365 - Lower use of statins among patients with peripheral artery disease compared with those with coronary heart disease

ESC Premium Access

Lower use of statins among patients with peripheral artery disease compared with those with coronary heart disease

Session: Poster Session 1 - Lipids

Topic: Drug therapy

Speaker: Doctor M. Farkouh (Los Angeles, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Michael Farkouh

Cedars-Sinai Health System, Los Angeles (United States of America)

3 presentations

1 follower

14 more presentations in this session

Patient characteristics and treatment patterns in patients on lipid-lowering therapies following an acute coronary syndrome in France

Speaker: Professor E. Bruckert (Paris, FR)

What is the most important residual risk after achievement of appropriate low-density lipoprotein cholesterol lowering therapy in secondary prevention of Japanese patients?

Speaker: Doctor A. Endo (Izumo, JP)

Association of adherence and treatment intensity of lipid-lowering therapy with cardiovascular outcomes and all-cause mortality in very high-risk patients in Germany

Speaker: Professor I. Ahrens (Cologne, DE)

Relative fat mass (RFM) is a better predictor of dyslipidemia and metabolic syndrome than body mass index (BMI).

Speaker: Doctor O. Kobo (Hadera, IL)

Low levels of low density lipoprotein cholesterol and cardiovascular, cancer and all-cause mortality outcomes

Speaker: Professor K. Sung (Seoul, KR)

Access the full session

Poster Session 1 - Lipids

Speakers: Doctor M. Farkouh, Professor E. Bruckert, Doctor A. Endo, Professor I. Ahrens, Doctor O. Kobo...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources